Predictive value of label-free surface-enhanced Raman spectroscopy for locally advanced gastric cancer following neoadjuvant chemoimmunotherapy
This study demonstrates that label-free SERS can effectively predict prognosis in NACI-treated LAGC patients and shows promise in molecular and pathological profiling, supporting its potential for clinical application.
Authors
- Luke Zhang (ORCID: https://orcid.org/0009-0009-8501-5781)
- Wenfang Wang (ORCID: https://orcid.org/0000-0003-1603-6166)
- Huan Zhang (ORCID: https://orcid.org/0000-0002-9838-0624)
- Xinran Wang (ORCID: https://orcid.org/0000-0003-1552-1805)
- Bowen Shi (ORCID: https://orcid.org/0000-0002-1231-7289)
- Kangning Wang (ORCID: https://orcid.org/0000-0001-6690-0149)
- Weiwu Yao (ORCID: https://orcid.org/0000-0002-1536-9324)
- Jinling Jiang (ORCID: https://orcid.org/0000-0002-3487-0675)
- Fei Yuan (ORCID: https://orcid.org/0000-0002-1898-5114)
Institutions
- East China University of Science and Technology (CN)
- Shanghai Jiao Tong University (CN)
- Fudan University (CN)
- Ruijin Hospital (CN)
- Huadong Hospital (CN)
- Tongren Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-19
- DOI
- https://doi.org/10.3389/fimmu.2025.1666860
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China